4.3 Review

Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside

Journal

BIOMARKERS
Volume 16, Issue 6, Pages 466-475

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/1354750X.2011.580006

Keywords

GDF-15; cardiovascular disease; myocardial protection

Funding

  1. National Basic Research Program of China [2007cb512107, 2011CB503903]
  2. National Science Foundation of China [81070078]
  3. Beijing Municipal Natural Science Foundation [7102158]

Ask authors/readers for more resources

Context: Growth differentiation factor 15 (GDF-15) is a novel cytokine showing close association with cardiovascular diseases. The biological mechanism and clinical use of GDF-15 in cardiovascular diseases have been well demonstrated. We review recent investigations from both basic research and clinical trials into the biological role of GDF-15. Methods: The data were obtained mainly from MedLine via PubMed and from our own investigations. Results: Laboratory investigations revealed that GDF-15 has biphasic effects on cellular survival by several signaling pathways. GDF-15 participates in several cardiovascular pathological processes such as cardiac remodeling, ischemia/reperfusion injury and atherosclerotic plaque formation. As well, GDF-15 was found a prognostic biomarker of heart failure and acute coronary syndrome. The evidence for diagnostic or therapeutic utility is poor. Conclusion: GDF-15 has great potential as a biomarker in cardiovascular diseases, especially for prognosis, and is seen as a myocardial protective cytokine, but the exact mechanism of GDF-15 in cardiovascular diseases remains unknown.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available